Current Events

DETROIT — The deeper General Motors digs into its vast portfolio of vehicles, the more safety problems it finds.

The announcement on Monday that G.M. would recall another 8.4 million cars and trucks for a range of defects appears to be a direct result of the company’s new found vigilance to rooting out safety issues.

Click here to read more.

WASHINGTON — A prominent compensation expert hired by General Motors is scheduled to announce a plan here on Monday to distribute money to victims of accidents caused by the automaker’s defective ignition switch.

But the payouts — which could cost G.M. billions of dollars — may not fully put the worst safety crisis in the company’s 106-year history behind it. While many victims and their families will be compensated, federal prosecutors and congressional investigators say that G.M. remains in their cross hairs for possible criminal behavior related to the handling of the defective vehicles.

Click here to read more.

WASHINGTON — A $1 million starting point for each death anchors the formula to pay families of those who died in accidents caused by a defective ignition switch in General Motors cars, under a plan unveiled Monday by a compensation expert hired by the automaker.

The plan, announced by the expert, Kenneth R. Feinberg, is broad and inclusive, and seems certain to account for deaths beyond the 13 that G.M. has publicly linked to the defect.

Click here to read more.

The U.S. Food and Drug Administration warned on Thursday against using a lidocaine solution as a pain reliever on teething babies' gums, saying it can cause deaths and serious injuries in infants and toddlers.

The agency will require a boxed warning on the label for prescription oral viscous lidocaine 2 percent solution to highlight that it should not be used for teething pain, the FDA said in a statement.

Click here to read more.

The US Food and Drug Administration has ordered GlaxoSmithKline to review its manufacturing operations globally after finding that its Canadian subsidiary violated quality requirements during the manufacture of its flu vaccine FluLaval.

Click here to read more.

(Reuters) - A GlaxoSmithKline Plc plant in Canada that makes the flu vaccine Flulaval has been cited by the U.S. Food and Drug Administration for failing to meet quality control standards. 

GSK said it is working to rectify the problems and does not expect a delay in distributing the vaccine for the 2014-2015 flu season. The company typically starts shipping the product at the end of July.

Click here to read more.

General Motors Co. said Tuesday a Chinese auto supplier built the parts at issue in its recall of 3.4 million cars for ignition switch problems linked to eight crashes and six injuries.

The June 16 ignition recall of the Chevrolet Impala and Monte Carlo; Cadillac DTS and Deville; and Buick LaCrosse and Lucerne is similar to GM’s delayed recall of 2.6 million Cobalts, Ions and other cars linked to 13 deaths and 54 crashes due to faulty ignition switches.

Click here to read more.

For years, Dr. Harry Lever, a cardiologist at the Cleveland Clinic, has been warning nearly anyone who would listen of his growing suspicions about generic versions of a widely used heart drug, Toprol XL.

Patient after patient, he said, would visit his office complaining of chest pains or other symptoms after switching from the brand-name version, made by AstraZeneca, to a generic product, often one made in India. When he switched them back to the brand — or to another generic — the symptoms disappeared, he said. Dr. Lever wrote a letter outlining his concerns to the Food and Drug Administration in 2012, and this year, he traveled to Washington to try to get the attention of Congress.

Click here to read more.

U.S. auto-safety regulators are looking into complaints that exhaust fumes, which can contain potentially lethal carbon monoxide, may build up inside Ford Motor Co. (F) sport-utility vehicles.

The National Highway Traffic Safety Administration action on model year 2011-2014 Explorers follows reports filed by SUV owners and a lawsuit that contends Dearborn, Michigan-based Ford “knew or should have known” that hundreds of thousands of its vehicles are dangerous.

Click here to read more.

A Louisiana federal judge said Friday that Takeda Pharmaceuticals Co. Ltd. intentionally destroyed evidence that would have helped the plaintiffs in a $9 billion bellwether lawsuit over claims the company hid the cancer risks of diabetes drug Actos to keep sales high.

Click here to read more.

The US Food and Drug Administration has told manufacturers of prescription testosterone treatments for men that they need to add a warning on their drug label about an increased risk of blood clots in the veins.

Such clots can lead to complications such as deep vein thrombosis, which causes severe pain, or a life-threatening pulmonary embolism, which occurs when a clot breaks off and travels through the veins into the lungs.

Click here to read more.